2025-04-04 20:37:22
Latest Post
Sai Life Sciences sets up Peptide Research Center in India
Netweb Technologies Ltd receives PLI Incentive Under IT Hardware Scheme 2.0
BHEL signs contract for ± 800 kV, 6000 MW Bhadla-Fatehpur LCC HVDC Terminal Station along with AC Transmission at Bhadla and Fatehpur
DEE Development Engineers Limited receives order worth approx. Rs. 55 crores- SURATWWALA BUSINESS GROUP Ltd purchases new commercial office space
Stock Report
Pharmaids Pharmaceuticals Q3FY22 PAT at Rs. 1.42 lakhs
Posted On : 2022-01-28 15:06:58( TIMEZONE : IST )
PHARMAIDS PHARMACEUTICALS LTD. has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 0.7239 crores during the period ended December 31, 2021 as compared to Rs. 0.5712 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 0.0142 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.0727 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 0.01 for the period ended December 31, 2021 as compared to Rs. 0.07 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 0.7239 crs | ₹0.5712 crs |  26.73% |
| Net Profit | ₹0.0142 crs | ₹0.0727 crs |  -80.47% |
| EPS | ₹0.01 | ₹0.07 | -85.71% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 0.7239 crores during the period ended December 31, 2021 as compared to Rs.3.41 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.0142 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.0097 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.01 for the period ended December 31, 2021 as compared to Rs.0.01 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 0.7239 crs | ₹3.41 crs | -78.77% |
| Net Profit | ₹0.0142 crs | ₹0.0097 crs | 46.39% |
| EPS | ₹0.01 | ₹0.01 |  0.00% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.3.6367 crores during the 9 Months period ended December 31, 2021 as compared to Rs.6.6922 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.0971 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.0503 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.0.09 for the 9 Months period ended December 31, 2021 as compared to Rs.0.05 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹3.6367 crs | ₹6.6922 crs | -45.66% |
| Net Profit | ₹0.0971 crs | ₹0.0503 crs | 93.04% |
| EPS | ₹0.09 | ₹0.05 | 80.00% |
Shares of PHARMAIDS PHARMACEUTICALS LTD. was last trading in BSE at Rs. 14.90 as compared to the previous close of Rs. 15.40. The total number of shares traded during the day was 13879 in over 153 trades.
The stock hit an intraday high of Rs. 15.75 and intraday low of 14.70. The net turnover during the day was Rs. 207573.00.
